Evaluation of body composition and biochemistry of patients with chronic kidney disease undergoing non-dialysis treatment

Authors

DOI:

https://doi.org/10.12957/demetra.2022.63144

Keywords:

Renal Insufficiency Chronic. Body Composition. Nutritional Status. Anthropometry.

Abstract

Introduction: The study evaluated the body composition and biochemical tests of patients with chronic kidney disease (CKD) undergoing non-dialysis treatment. Method: Cross-sectional study including patients with CKD stages 3 to 5, older than 60 years (n=138). Body Mass Index (BMI), calf (CC), brachial (BC), brachial muscle (BMC), and waist circumferences (WC) and triceps skinfold thickness (TST) were evaluated. Through bioimpedance, it was obtained: lean tissue mass (LTM), LTM index, body cell mass (BCM), adipose tissue mass (ATM), ATM index, fat percentage, total body water (TBW), extracellular water (ECW) and intracellular water (ICW). Biochemical tests, such as blood glucose, lipid profile, uric acid, urea, creatinine, vitamin D, and minerals were evaluated. Descriptive analysis was performed according to sex and compared using Student's t, Mann-Whitney, and chi-square tests. Simple linear regression was performed to predict body composition and biochemical tests, according to glomerular filtration rate (GFR), adjusted for sex and age. Results: The prevalence of overweight was 70.4% in females and 53.7% in males. The percentage of fat was high in 90.7% of women and 91.7% of men. On the other hand, muscle mass depletion had a prevalence of 35.2% and 30.0%, respectively. Men presented higher values of BMC, BCM, LTM, LTM index, TBW, ECW and ICW. Women, presented higher values of BMI, PCT, body fat, ATM and ATM index. GFR correlated with serum urea (r2 = 0.279), potassium (r2 = 0.018) and HDL (r2 = 0.202). Conclusion: High prevalence of changes in body composition and biochemical tests were identified in patients with CKD undergoing non-dialysis treatment.

Author Biography

Priscila Moreira de Lima Pereira, Universidade Federal de Juiz de Fora

Nutricionista (UFJF), Especialista em Saude Pública (UNINTER), Especialista em Nefrologia Multidisciplinar (UFMA), Mestra em Saude Coletiva (UFJF) e Doutoranda em Saude Coletiva (UFJF)

References

Referencias

Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PloS one. 2016; 11(7). https://doi.org/10.1371/journal.pone.0158765

Levey AS, de Jong PE, Coresh J, Nahas MEl, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17-28. https://doi.org/10.1038/ki.2010.483

Kalantar-Zadeh, Kamyar, and Denis Fouque. "Nutritional management of chronic kidney disease." New England Journal of Medicine. 2017; 377 (18): 1765-1776. https://doi.org/10.1056/NEJMra1700312

Fahal IH. Uraemic sarcopenia: aetiology and implications. Nephrol Dial Transplant. 2014; 29(9): 1655-1665.

Carrero JJ, Johansen KL, Lindholm B, Stenvinkel P, Cuppari L, Avesani CM. Screening for muscle wasting and dysfunction in patients with chronic kidney disease. Kidney Int. 2016; 90(1):53-66.

Wing MR, Yang W, Teal V. Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: Findings from the chronic renal insufficiency cohort study. Obesity. 2014; 22(5):1359-1366.

Instituto Brasileiro de Geografia e Estatística (IBGE). Estimativas da população, 2015. Available from: URL: https://www.ibge.gov.br/estatisticas/sociais/populacao/9103-estimativas-de-populacao.html?edicao=17283&t=downloads

Pescatello LS, Arena R, Riebe D, Thompson PD. ACSM’s guidelines for exercise testing and prescription. 9a ed. Baltimore: Lippincott Williams & Wilkins; 2014. 2-18.

Lipschitz DA. Screening for nutritional status in the elderly. Prim Care.1994; 21(1):55-67.

Fagundes AA, Barros DC, Dura HA, Sardinha LMV, Pereira MM, Leão MM. SISVAN: orientações básicas para a coleta, processamento, análise de dados e informação em serviços de saúde. Ministério da Saúde. 2004.

WHO Expert Committee on Physical Status. The Use and Interpretation of Anthropometry: Report of a WHO Expert Committee. Geneva, Switzerland: World Health Organization; 1995. World Health Organization Technical Report Series 854.

Frisancho AR. Anthropometric standards for the assessment of growth and nutritional status. Ann Arbor (MI): University of Michigan Press; 1990.

Harrison GG, Buskirk ER, Lindsay Carter JE, Johnston FE, Lohman TG, Pollock ML, Roche AF & Wilmore J (1988): Skinfold thicknesses and measurement technique. In Anthropometric Standardisation Reference Manual, eds TG Lohman, AF Roche & R Martorell, p 55–70.

WHO, World Health Organization. Obesity: Preventing and managingthe global epidemic – Report of a WHO consultation on obesity. Geneva; 2000..

Wieskotten, S, Moissl, U, Chamney, P, Wabel, P. Reference ranges for human body composition and fluid overload. Measurement. 2006; 27: 921-33.

Lohman T.G, Champaign, I.L. Advances in body composition assessment. Champaign, IL: Human Kinetics Publishers, 1992.

Nemer, A.G.A.; Neves, F.J.; Ferreira, J.E.S.editors; Manual de solicitação e interpretação de exames laboratoriais, 1ed, Revinter, 2010.

Xavier HT, Izar MC, Faria Neto JR, Assad MH, Rocha VZ, Sposito AC, et al. V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose. Arq Bras Cardiol. 2013; 101:1-20.

Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12

KDIGO 2012. Clinical Practice Guideline for the Evaluation and Management of chronic Kidney Disease. Kidney Int Suppl, 2013; 3(5).

Pereira AC, Carminatti M, Fernandes NMS, Tirapani LS, Faria RS, Grincenkov FRS, et al. Associação entre fatores de risco clínicos e laboratoriais e progressão da doença renal crônica pré-dialítica. J Bras Nefrol 2012;34:68-75.

Filho VJC, Rodrigues RAC. Progressão da doença renal crônica: experiência ambulatorial em Santarém – Pará. J Bras Nefrol. 2013; 35: 99-106.

Pinho NA, Silva GV, Pierin AMG. Prevalência e fatores associados à doença renal crônica em pacientes internados em um hospital universitário na cidade de São Paulo, SP, Brasil. J Bras Nefrol. 2015; 37: 91-97.

Fontes, Bruna Carvalho, et al. "Efeitos da dieta hipoproteica sobre os perfis lipídico e antropométrico de pacientes com doença renal crônica em tratamento conservador." J Bras Nefrol. 2018; 40 (3): 225-232.

Ahima RS, Lazar MA. The health risk of obesity—better metrics imperative. Science. 2013; 341 (6148): 856-858.

Carrero JJ, Avesani CM. Pros and cons of body mass index as a nutritional and risk assessment tool in dialysis patients. In: Seminars in dialysis. 2015. p. 48-58.

Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Annals of Internal Medicine. 2006; 144: 21-28.

Stenvinkel P, Alvestrand A. Inflammation in end‐stage renal disease: sources, consequences, and therapy. Semin Dial. 2002; 15: 329-337.

Elsayed EF, Tighiouart H, Weiner DE, Griffith J, Salem D, Levey AS, et al. Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis. 2008; 52: 49-57.

Workeneh BT, Mitch WE. Review of muscle wasting associated with chronic kidney disease. The American Journal of Clinical Nutrition. 2010; 91(4): 1128S-1132S.

Hung SC, Lai YS, Kuo KL, et al. Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies. J Am Heart Assoc. 2015;4:e001918.

Wabel P, Rode C, Moissl U, Chamney P, Wizemann V. Accuracy of bioimpedance spectroscopy (BIS) to detect fluid status changes in hemodialysis patients. Nephrol Dial Transplant. 2007; 22(6): 129.

Wizemann V, Moissl U, Chamney O, Wabel P. Differences in hydration status between healthy, Pre-ESRD, dx and tx subgroups can be distinguished clearly with bioimpedance spectroscopy. Physiol Meas. 2006:1.

Hecking M, Antlanger M, Winnicki W, et al. Blood volume-monitored regulation of ultrafiltration in fluidoverloaded hemodialysis patients: study protocol for a randomized controlled trial. Trials. 2012; 13: 79.

Marcelli D, Usvyat LA, Kotanko P, et al. Body composition and survival in dialysis patients: results from an international cohort study. Clin J Am Soc Nephrol. 2015;10:1192–1200.

Zoccali C, Moissl U, Chazot C, et al. Chronic fluid overload and mortality in ESRD. J Am Soc Nephrol. 2017;28:2491–2497.

Zhou, Yunan, Peter Höglund, and Naomi Clyne. "Comparison of DEXA and bioimpedance for body composition measurements in nondialysis patients with CKD." Journal of Renal Nutrition 29.1 (2019): 33-38.

Lin, Ting-Yun, et al. Body composition is associated with clinical outcomes in patients with non–dialysis-dependent chronic kidney disease. Kidney international. 2018; 93 (3): 733-740.

Hsu CY, Chertow GM. Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrol Dial Transplant. 2002; 17: 1419-1425

Campbell KL, Ash S, Davies PS, Bauer JD. Randomized controlled trial of nutritional counseling on body composition and dietary intake in severe CKD. Am J KidneyDis. 2008; 51: 748-758

Published

2022-07-30

How to Cite

Pereira, P. M. de L., & Candido, A. P. C. (2022). Evaluation of body composition and biochemistry of patients with chronic kidney disease undergoing non-dialysis treatment. DEMETRA: Food, Nutrition & Health, 17, e63144. https://doi.org/10.12957/demetra.2022.63144

Issue

Section

Clinical Nutrition